NUS team develops new way to use chemo to fight cancer

Fighting cancer: Dr Chow, who led the NUS team, hopes to start in-human clinical trials in about two years. — The Straits Times / Asia News Network

A STUDY led by the National University of Singapore (NUS) has found a way to use chemotherapy to shrink cancerous tumours while also minimising relapses and harmful side effects.

The team has managed to make a common chemotherapy drug, epirubicin, more effective in targeting cancer stem cells, which cause tumours to grow.